474
Views
74
CrossRef citations to date
0
Altmetric
Review

Natural killer cell–dendritic cell crosstalk in the initiation of immune responses

, , &
Pages S49-S59 | Published online: 24 Nov 2005

Bibliography

  • MORETTA L, MORETTA A: Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO (2004) 23(2):255–259.
  • RAULET DH: Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. lininunol. (2004) 5(10):996–1002.
  • VIVIER E, BIRON CA: A pathogen receptor on natural killer cells. Science (2002) 296(5570:1248–1249.
  • BIRON CA, NGUYEN KB, PIEN GC, COUSENS LP, SALAZAR-MATHER TP: Natural killer cells in antiviral defense: function and regulation by innate cytokines. Ann. Rev lininunol. (1999) 17:189–220.
  • IWASAKI A, MEDZHITOV R: Toll-like receptor control of the adaptive immune responses. Nat. Inununol (2004) 5 (10): 987–995.
  • FERNANDEZ NC, LOZIER A, FLAMENT C et al: Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. (1999) 5:405–411.
  • SHORTMAN K, LIU YJ: Mouse and human dendritic cell subtypes. Nat. Rev Inllnunol. (2002) 2(3):151–161.
  • MORETTA A: Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. lininunol. (2002) 2(12):957–964.
  • NGUYEN KB, SALAZAR-MATHER TP, DALOD MY et al: Coordinated and distinct roles for IFN-alpha/beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. lininunol. (2002) 169(8):4279–4287.
  • GEROSA F, GOBBI A, ZORZI P et al: The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. lininunol. (2005) 174:727–734.
  • DALOD M, HAMILTON T, SALOMON R et al.: Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. (2003) 197(7):885–898.
  • GRANUCCI F, ZANONI I, PAVELKA Net al.: A contribution of mouse dendritic cell-derived IL-2 for NK cell activation. J. Exp. Med. (2004) 200(3):287–295.
  • KOKA R, BURKETT P, CHIEN M et al: Cutting edge: murine dendritic cells require IL-15Ralpha to prime NK cells. J. lininunol. (2004) 173(6):3594–3598.
  • FERLAZZO G, PACK M, THOMAS D eta].: Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Li. USA (2004) 101(47):16606–16611.
  • JINUSHI M, TAKEHARA T, KANTO T et al.: Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Inllnunol. (2003) 170(3):1249–1256.
  • GEROSA F, BALDANI-GUERRA B, NISII C et al: Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. (2002) 195(3):327–333.
  • BORG C, ABDELALI J, LADERACH D eta].: NK cell activation by dendritic cells (DC) require the formation of a synapse leading to IL-12 polarization in DC. Blood (2004) 104(10):3267–3275.
  • KIKUCHI T, HAHN CL, TANAKA S eta].: Dendritic cells stimulated with Actinobacillus actinoinyceteincomitans elicit rapid gamma interferon responses by natural killer cells. Infect. Inllnun. (2004) 72(9):5089–5096.
  • YU Y, HAGIHARA M, ANDO K et al.: Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.' Inllnunol (2001) 166: 1590-1600.
  • COLONNA M, TRINCHIERI G, LIU YJ: Plasmacytoid dendritic cells in immunity. Nat. Inununol (2004) 5(12):1219–1226.
  • PICCIOLI D, SBRANA S, MELANDRI E, VALIANTE NM: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. (2002) 195 (3):335–341.
  • MAILLIARD RB, SON YI, REDLINGER R et al: Dendritic cells mediate NK cell help for Thl and CTL responses: two-signal requirement for the induction of NK cell helper function. J. lininunol. (2003) 171(5):2366–2373.
  • TERME M, TOMASELLO E, MARUYAMA K et al: IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. lininunol. (2004) 172(10)5957–5966.
  • CARBONE E, TERRAZZANO G, RUGGIERO G et al: Recognition of autologous dendritic cells by human NK cells. Eur. lininunol. (1999) 29(12):4022–4029.
  • FERLAZZO G, TSANG ML, MORETTA L et al: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. .1 Exp. Med. (2002) 195(3):343–351.
  • DELLA CHIESA M, VITALE M, CARLOMAGNO S et al: The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. lininunol. (2003) 33 (6) :1657–1666.
  • CARBONE E, TERRAZZANO G, MELIAN A et al: Inhibition of human NK cell-mediated killing by CD1 molecules. lininunol. (2000) 164(12):6130–6137.
  • HAYAKAWA Y, BERZINS SP, CROWE NY, GODFREY DI, SMYTH MJ: Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors. Nat. Inununol. (2004) 5(6):590–596.
  • WILSON JL, HEFFLER LC, CHARO J et al: Targeting of human dendritic cells by autologous NK cells. J. Inununol. (1999) 163(12):6365–6370.
  • SPAGGIARI GM, CAROSIO R, PENDE D eta].: NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur.j lininunol. (2001) 31(6):i656–i665.
  • FERLAZZO G, SEMINO C, MELIOLI G: HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. lininunol. Lett. (2001) 76(1):37–41.
  • HAYAKAWA Y, SCREPANTI V, YAGITA H et al.: NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. lininunol. (2004) 172(1):123–129.
  • RUGGERI L, CAPANNI M, URBANI E et al.: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 295(5562):2097–2100.
  • POOLEY JL, HEATH WR, SHORTMAN K: Cutting edge: intravenous soluble antigen is presented to CD4 t cells by CD8(-) dendritic cells, but cross-presented to CD8 t cells by CD8(+) dendritic cells. Immunol (2001) 166(9):5327–5330.
  • DEN HAAN JM, LEHAR SM, BEVAN MJ: CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. (2000) 192(12):1685–1696.
  • FERLAZZO G, THOMAS D, UN SL et al.: The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic../. Immunol (2004) 172(3):1455–1462.
  • VITALE M, CHIESA MD, CARLOMAGNO S et al: The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur. Immunol (2004) 34(6):1715–1722.
  • CAMPBELL JJ, QIN S, UNUTMAZ D et al: Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol (2001) 166(11):6477–6482.
  • HANNA J, WALD 0, GOLDMAN-WOHL D et al: CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. Blood (2003) 102(5):1569–1577.
  • INNGJERDINGEN M, DAMAJ B, MAGHAZACHI AA: Expression and regulation of chemokine receptors in human natural killer cells. Blood (2001) 97(2):367–375.
  • SOZZANI S, ALLAVENA P, VECCHI A, MANTOVANI A: Chemokines and dendritic cell traffic. I Clin. Immunol (2000) 20(3):151–160.
  • MARTIN-FONTECHA A, THOMSEN LL, BRETT S et al: Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol (2004) 5(12):1260–1265.
  • BAJENOFF M, BREART B, HUANG H, ZIT VOGEL L, AL E: NK cells are slow motile cells localized in the lymph node outerparacortex where they make contacts with dendritic cells. In: Pasteur I Ed., Paris (2004).
  • BRAWAND P, FITZPATRICK DR, GREENFIELD BW et al: Murine plasmacytoid pre-dendritic cells generated from F1t3 ligand-supplemented bone marrow cultures are immature APCs. Immunol (2002) 169(12):6711–6719.
  • JOHNSTON B, KIM CH, SOLER D, EMOTO M, BUTCHER EC: Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. Immunol. (2003) 171(6):2960–2969.
  • SALAZAR-MATHER TP, ORANGE JS,BIRON CA: Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein lalpha (IVIIP-lalpha)-dependent pathways. I Exp. Med. (1998) 187:1–14.
  • LAMBRECHT BN, HAMMAD H: Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev Immunol (2003) 3(12):994–1003.
  • SAITO S, KASAHARA T, SAKAKURA S et al: Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua. Biochem. Biophys. Res. Commun. (1994) 200(1):378–383.
  • BLUMAN EM, BARTYNSKI KJ, AVALOS BR, CALIGIURI MA: Human natural killer cells produce abundant macrophage inflammatory protein-1 in response to monocyte-derived cytokines. Clin. Invest. (1996) 97:2722–2727.
  • FEHNIGER TA, HERBEIN G, YU H et al: Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. I Immunol (1998) 161:6433–6438.
  • OLIVA A, KINTER AL, VACCAREZZA M et al.: Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. I Clin. Invest. (1998) 102:223–231.
  • ORTALDO JR, BERE EW, HOD GE D, YOUNG HA: Activating Ly-49 NK receptors: central role in cytokine and chemokine production. J. Immunol (2001) 166(8):4994–4999.
  • BORG C, TERME M, TAIEB J et al: Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects. J. Clin. Invest. (2004) 114(3):379–388.
  • ALBERTSSON PA, BASSE PH, HOKLAND M et al.: NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol (2003) 24(11):603–609.
  • VICARI AP, TREILLEUX I, LEBECQUE S: Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines. &min. Cancer Biol. (2004) 14(3):161–169.
  • FERLAZZO G, MUNZ C: NK cell compartments and their activation by dendritic cells. J. Immunol (2004) 172(3):1333–1339.
  • TOSI D, VALENTI R, COVA A et al: Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8(+) T cell responses against human tumor antigens. Immunol (2004) 172(9):5363–5370.
  • COOPER MA, FEHNIGER TA, TURNER SC et al: Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood (2001) 97(10):3146–3151.
  • VAN DEN BROEKE LT, DASCHBACH E, THOMAS EK, ANDRINGA G, BERZOFSKY JA: Dendritic cell-induced activation of adaptive and innate antitumor immunity. Immunol(2003) 171(11):5842–5852.
  • MOCIKAT R, BRAUMULLER H, GUMY A et al.: Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity (2003) 19(4):561–569.
  • KELLY JM, DARCY PK, MARKBY JL et al: Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol (2002) 3(1):83–90.
  • HAYAKAWA Y, KELLY JM, WESTWOOD JA et al.: Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforM. I Immunol (2002) 169(10):5377–5381.
  • KHAKOO SI, THIO CL, MARTIN MP et al.: HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 305(5685)872–874.
  • WARFIELD KU, PERKINS JG, SWENSON DL et al: Role of natural killer cells in innate protection against lethal ebola virus infection. ./. Exp. Med. (2004) 200(2):169–179.
  • MARTIN MP, GAO X, LEE JH et al: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. (2002) 31(4):429–434.
  • SCOTT-ALGARA D, TRUONG LX, VERSMISSE P et al: Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Inonunol. (2003) 171(145663–5667.
  • ORANGE JS, BIRON CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-y production and antiviral defense. J. bronunol. (1997) 156:1138–1142.
  • DALOD M, SALAZAR-MATHER TP, MALMGAARD L et al.: Interferon alpha/ beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. .1 Exp. Med. (2002) 195(4):517–528.
  • KRUG A, FRENCH AR, BARCHET W et al.: TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity(2004) 21(1):107–119.
  • BROWN MG, DOKUN AO, HEUSEL JW et al.: Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science (2001) 292 (5518):934–937.
  • LEE SH, GIRARD S, MACINA D et al: Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. (2001) 28(1):42–45.
  • DANIELS KA, DEVORA G, LAI WC et al.: Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to 1y4911. J Exp. Med. (2001) 194(429–44.
  • SMITH HR, HEUSEL JW, MEHTA IK et al.: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA (2002) 99(13):8826–8831.
  • ARASE H, MOCARSKI ES, CAMPBELL AE, HILL AB, LANIER LL: Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 296:1323–1326.
  • LEE SH, ZAFER A, DE REPENTIGNY Y et al: Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. (2003) 197(4):515–526.
  • DOKUN AO, KIM S, SMITH HR et al:Specific and nonspecific NK cell activation during virus infection. Nat. bronunol. (2001) 2(10):951–956.
  • ANDREWS DM, SCALZO AA, YOKOYAMA WM, SMYTH MJ, DEGLI-ESPOSTI MA: Functional interactions between dendritic cells and NK cells during viral infection. Nat. bronunol. (2003) 4(2):175–181.
  • VALTEAU-COUANET D, LEBOULAIRE C, MAINCENT K et al: Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients. Blood (2002) 100(42554–2561.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.